Paul Beavis, PhD, CRI Lloyd J. Old STAR The University of Melbourne (Australia) Area of Research: All Cancers, Lung Cancer, Multiple Myeloma, Sarcoma Dr. Paul Beavis is pioneering strategies to enhance CAR T cell therapy for solid cancers. His research focuses on overcoming immunosuppressive tumor environments, activating anti-tumor immunity, and improving CAR T cell persistence and penetration. With over 10,000 citations and significant publications in top-tier journals, Dr. Beavis is a renowned leader in the field. His innovative CAR T technology will enter a phase I clinical trial in 2025 at the Peter MacCallum Cancer Centre. Projects and Grants Enhancing the Efficacy of Adoptive Cellular Therapy through Advanced Genome Engineering The University of Melbourne | All Cancers | 2024
